IP analytics firm Clarivate beats Q3 estimates; raises FY sales view, keeps profit view

Reuters
Oct 29
IP analytics firm Clarivate beats Q3 estimates; raises FY sales view, keeps profit view

Overview

  • Clarivate Q3 2025 revenue and adjusted EPS beat analyst expectations

  • Company repurchased 11.7 mln shares and repaid $100 mln of debt in Q3

  • Adjusted net income and EBITDA exceeded analyst estimates

Outlook

  • Clarivate raises full-year 2025 revenue outlook to $2.42 bln-$2.45 bln

  • Company maintains 2025 adjusted EBITDA guidance at $940 mln-$1.00 bln

  • Clarivate keeps 2025 adjusted diluted EPS forecast at $0.60-$0.70

Result Drivers

  • SUBSCRIPTION GROWTH - Organic subscription revenues increased 1.2%, driven by new sales and price increases

  • REVENUE MIX IMPROVEMENT - Co reports 800 bps improvement in recurring revenue mix to 88%

  • VALUE CREATION PLAN - Co attributes improved financial performance to its Value Creation Plan, focusing on product and AI development

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$623.10 mln

$570 mln (8 Analysts)

Q3 Adjusted EPS

Beat

$0.18

$0.16 (10 Analysts)

Q3 Adjusted Net Income

Beat

$119.30 mln

$107.90 mln (5 Analysts)

Q3 Net Income

-$28.30 mln

Q3 Adjusted EBITDA

Beat

$252.40 mln

$239.60 mln (6 Analysts)

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 6 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the professional information services peer group is "buy."

  • Wall Street's median 12-month price target for Clarivate PLC is $4.90, about 25.7% above its October 28 closing price of $3.64

  • The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 6 three months ago

Press Release: ID:nPrerKKTda

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10